CKMH Nephrology

My Settings
Relevant Content
Time of Day as a Biological Variable in Cardiovascular and Kidney Disease Research
Time-of-day is a fundamental biological variable that needs to be consider...
Finerenone Plus Empagliflozin: How Low Can We Go, and How Much Does Blood Pressure Matter?
Hypertension, Volume 83, Issue 9, Page e27364, September 1, 2026.
Letter by Hu et al Regarding Article, “Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage”
Circulation, Volume 154, Issue 6, Page e235-e236, August 11, 2026.
Response by Poudel and Susztak to Letter Regarding Article, “Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage”
Circulation, Volume 154, Issue 6, Page e237-e238, August 11, 2026.
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials
Extension follow-up studies address long-term questions beyond the parent...
Comprehensive Clinical Approach to Cardiovascular Kidney Metabolic Syndrome
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Researchers at Heart
uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome
Circulation Research, Volume 139, Issue 1, Page e328563, June 19, 2026. Strategies for Optimizing Heart Failure Care in the Older Adult
Heart failure (HF) in older adults is a growing and distinct clinical chal...